Stay updated on LEGEND Clinical Trial: Lanifibranor and EmpaGliflozin in NASH with T2DM

Sign up to get notified when there's something new on the LEGEND Clinical Trial: Lanifibranor and EmpaGliflozin in NASH with T2DM page.
Latest website image capture
Clouds background image

Latest updates to the LEGEND Clinical Trial: Lanifibranor and EmpaGliflozin in NASH with T2DM page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    A new revision entry v3.6.5 is added to the study's version history, and the previous revision v3.6.4 is removed from the visible history to update the audit trail.
    Difference
    0.1%
    Check dated 2026-08-08T23:21:45.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The latest version shows major study-data sections and QC status, along with the Returned date. This reflects the addition of structured data areas in the record history.
    Difference
    1%
    Check dated 2026-08-01T20:05:03.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The study history shows a new page revision label: v3.6.4, replacing the previous v3.6.3. This indicates an updated page build of the record history rather than changes to the study data.
    Difference
    0.1%
    Check dated 2026-07-25T17:03:53.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The latest version entry shows Results Submitted and Revision: v3.6.3. It replaces the previous No Results Posted and Revision: v3.6.2.
    Difference
    0.2%
    Check dated 2026-07-04T04:54:09.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The record history now shows a new revision tag v3.6.2 replacing v3.6.0, indicating a patch-level update to the page’s revision metadata. This change relates to the history UI rather than the study data.
    Difference
    0.1%
    Check dated 2026-06-27T03:19:27.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The recruitment status indicates the study is not currently enrolling participants, representing a shift in enrollment activity; a new revision tag v3.6.0 was added and the previous v3.5.5 tag was removed.
    Difference
    0.3%
    Check dated 2026-06-12T17:23:35.000Z thumbnail image

Stay in the know with updates to LEGEND Clinical Trial: Lanifibranor and EmpaGliflozin in NASH with T2DM

Enter your email address, and we'll notify you when there's something new on the LEGEND Clinical Trial: Lanifibranor and EmpaGliflozin in NASH with T2DM page.